CA2692744A1 - Appareil et procede pour recolter des substances biologiques provenant d'oeufs - Google Patents
Appareil et procede pour recolter des substances biologiques provenant d'oeufs Download PDFInfo
- Publication number
- CA2692744A1 CA2692744A1 CA 2692744 CA2692744A CA2692744A1 CA 2692744 A1 CA2692744 A1 CA 2692744A1 CA 2692744 CA2692744 CA 2692744 CA 2692744 A CA2692744 A CA 2692744A CA 2692744 A1 CA2692744 A1 CA 2692744A1
- Authority
- CA
- Canada
- Prior art keywords
- egg
- tray
- eggs
- opening
- pan
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 235000013601 eggs Nutrition 0.000 title claims abstract description 344
- 238000000034 method Methods 0.000 title claims abstract description 64
- 238000003306 harvesting Methods 0.000 title abstract description 12
- 229960000074 biopharmaceutical Drugs 0.000 title description 10
- 239000012530 fluid Substances 0.000 claims description 60
- 230000033001 locomotion Effects 0.000 claims description 45
- 238000004140 cleaning Methods 0.000 claims description 8
- 230000005484 gravity Effects 0.000 claims description 4
- 210000001643 allantois Anatomy 0.000 claims description 3
- 210000002257 embryonic structure Anatomy 0.000 claims description 3
- 238000005520 cutting process Methods 0.000 abstract description 25
- 241000700605 Viruses Species 0.000 description 56
- 206010022000 influenza Diseases 0.000 description 24
- 241000271566 Aves Species 0.000 description 23
- 230000008569 process Effects 0.000 description 21
- 241000712461 unidentified influenza virus Species 0.000 description 19
- 101710154606 Hemagglutinin Proteins 0.000 description 18
- 101710093908 Outer capsid protein VP4 Proteins 0.000 description 18
- 101710135467 Outer capsid protein sigma-1 Proteins 0.000 description 18
- 101710176177 Protein A56 Proteins 0.000 description 18
- 239000000185 hemagglutinin Substances 0.000 description 18
- 108010006232 Neuraminidase Proteins 0.000 description 14
- 102000005348 Neuraminidase Human genes 0.000 description 14
- 230000000890 antigenic effect Effects 0.000 description 14
- 208000037797 influenza A Diseases 0.000 description 11
- 241000287828 Gallus gallus Species 0.000 description 10
- 235000013330 chicken meat Nutrition 0.000 description 10
- 230000008878 coupling Effects 0.000 description 10
- 238000010168 coupling process Methods 0.000 description 10
- 238000005859 coupling reaction Methods 0.000 description 10
- 238000007689 inspection Methods 0.000 description 10
- 238000012545 processing Methods 0.000 description 10
- 108090000623 proteins and genes Proteins 0.000 description 10
- 230000003068 static effect Effects 0.000 description 10
- 241000282412 Homo Species 0.000 description 9
- 208000015181 infectious disease Diseases 0.000 description 8
- 210000004379 membrane Anatomy 0.000 description 8
- 239000012528 membrane Substances 0.000 description 8
- 102000004169 proteins and genes Human genes 0.000 description 8
- 230000003612 virological effect Effects 0.000 description 8
- 241000712431 Influenza A virus Species 0.000 description 7
- 241000286209 Phasianidae Species 0.000 description 7
- 210000004027 cell Anatomy 0.000 description 7
- 208000037798 influenza B Diseases 0.000 description 7
- 210000001161 mammalian embryo Anatomy 0.000 description 7
- 210000003205 muscle Anatomy 0.000 description 7
- 239000002245 particle Substances 0.000 description 7
- 229960005486 vaccine Drugs 0.000 description 7
- 241000272517 Anseriformes Species 0.000 description 6
- 241000282414 Homo sapiens Species 0.000 description 5
- 230000008859 change Effects 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 229910001220 stainless steel Inorganic materials 0.000 description 5
- 239000010935 stainless steel Substances 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- 239000002699 waste material Substances 0.000 description 5
- 206010011224 Cough Diseases 0.000 description 4
- 239000000427 antigen Substances 0.000 description 4
- 102000036639 antigens Human genes 0.000 description 4
- 108091007433 antigens Proteins 0.000 description 4
- 210000003711 chorioallantoic membrane Anatomy 0.000 description 4
- 238000010276 construction Methods 0.000 description 4
- 230000034994 death Effects 0.000 description 4
- 231100000517 death Toxicity 0.000 description 4
- 210000003278 egg shell Anatomy 0.000 description 4
- 229960003971 influenza vaccine Drugs 0.000 description 4
- 102000002322 Egg Proteins Human genes 0.000 description 3
- 108010000912 Egg Proteins Proteins 0.000 description 3
- 102000011931 Nucleoproteins Human genes 0.000 description 3
- 108010061100 Nucleoproteins Proteins 0.000 description 3
- 241000282887 Suidae Species 0.000 description 3
- 241000282898 Sus scrofa Species 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 230000000712 assembly Effects 0.000 description 3
- 238000000429 assembly Methods 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 210000001163 endosome Anatomy 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 230000004927 fusion Effects 0.000 description 3
- 230000002458 infectious effect Effects 0.000 description 3
- 208000037799 influenza C Diseases 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 102000005962 receptors Human genes 0.000 description 3
- 108020003175 receptors Proteins 0.000 description 3
- 230000000241 respiratory effect Effects 0.000 description 3
- 230000009385 viral infection Effects 0.000 description 3
- HVCOBJNICQPDBP-UHFFFAOYSA-N 3-[3-[3,5-dihydroxy-6-methyl-4-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-2-yl]oxydecanoyloxy]decanoic acid;hydrate Chemical compound O.OC1C(OC(CC(=O)OC(CCCCCCC)CC(O)=O)CCCCCCC)OC(C)C(O)C1OC1C(O)C(O)C(O)C(C)O1 HVCOBJNICQPDBP-UHFFFAOYSA-N 0.000 description 2
- 229930186217 Glycolipid Natural products 0.000 description 2
- 206010061598 Immunodeficiency Diseases 0.000 description 2
- 108060003951 Immunoglobulin Proteins 0.000 description 2
- 208000002979 Influenza in Birds Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 241000725681 Swine influenza virus Species 0.000 description 2
- 240000001068 Thogoto virus Species 0.000 description 2
- 230000001133 acceleration Effects 0.000 description 2
- 210000004712 air sac Anatomy 0.000 description 2
- 230000004075 alteration Effects 0.000 description 2
- 210000001691 amnion Anatomy 0.000 description 2
- 206010064097 avian influenza Diseases 0.000 description 2
- 206010006451 bronchitis Diseases 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 238000011109 contamination Methods 0.000 description 2
- 210000000805 cytoplasm Anatomy 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 210000002969 egg yolk Anatomy 0.000 description 2
- 210000002919 epithelial cell Anatomy 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 102000018358 immunoglobulin Human genes 0.000 description 2
- 229940072221 immunoglobulins Drugs 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 206010025482 malaise Diseases 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000002861 polymer material Substances 0.000 description 2
- 239000004814 polyurethane Substances 0.000 description 2
- 229920002635 polyurethane Polymers 0.000 description 2
- 244000144977 poultry Species 0.000 description 2
- 235000013594 poultry meat Nutrition 0.000 description 2
- 238000012958 reprocessing Methods 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 230000032258 transport Effects 0.000 description 2
- 229920000785 ultra high molecular weight polyethylene Polymers 0.000 description 2
- 210000001534 vitelline membrane Anatomy 0.000 description 2
- 241001664176 Alpharetrovirus Species 0.000 description 1
- 241000711404 Avian avulavirus 1 Species 0.000 description 1
- 241000713826 Avian leukosis virus Species 0.000 description 1
- 201000001178 Bacterial Pneumonia Diseases 0.000 description 1
- 241000120506 Bluetongue virus Species 0.000 description 1
- 208000014644 Brain disease Diseases 0.000 description 1
- 208000020446 Cardiac disease Diseases 0.000 description 1
- 208000003322 Coinfection Diseases 0.000 description 1
- 208000032274 Encephalopathy Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 208000002091 Febrile Seizures Diseases 0.000 description 1
- 241000710831 Flavivirus Species 0.000 description 1
- 241000710198 Foot-and-mouth disease virus Species 0.000 description 1
- 241000287826 Gallus Species 0.000 description 1
- 241001663880 Gammaretrovirus Species 0.000 description 1
- 241000608297 Getah virus Species 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 108060003393 Granulin Proteins 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 241000713196 Influenza B virus Species 0.000 description 1
- 241000713297 Influenza C virus Species 0.000 description 1
- 208000019693 Lung disease Diseases 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 102000012750 Membrane Glycoproteins Human genes 0.000 description 1
- 108010090054 Membrane Glycoproteins Proteins 0.000 description 1
- 108010052285 Membrane Proteins Proteins 0.000 description 1
- 102000018697 Membrane Proteins Human genes 0.000 description 1
- 241000711386 Mumps virus Species 0.000 description 1
- 241000710908 Murray Valley encephalitis virus Species 0.000 description 1
- 208000000112 Myalgia Diseases 0.000 description 1
- 208000009525 Myocarditis Diseases 0.000 description 1
- 201000002481 Myositis Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 241000702259 Orbivirus Species 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 206010033078 Otitis media Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 206010035737 Pneumonia viral Diseases 0.000 description 1
- 208000035415 Reinfection Diseases 0.000 description 1
- 206010027698 Respiratory signs and symptoms Diseases 0.000 description 1
- 241000712909 Reticuloendotheliosis virus Species 0.000 description 1
- 201000007981 Reye syndrome Diseases 0.000 description 1
- 208000036071 Rhinorrhea Diseases 0.000 description 1
- 206010039101 Rhinorrhoea Diseases 0.000 description 1
- 241001533467 Rubulavirus Species 0.000 description 1
- 208000020967 Sever disease Diseases 0.000 description 1
- 241000710960 Sindbis virus Species 0.000 description 1
- 101710172711 Structural protein Proteins 0.000 description 1
- 241000272534 Struthio camelus Species 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 241000710772 Yellow fever virus Species 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 241000701792 avian adenovirus Species 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 201000005008 bacterial sepsis Diseases 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- SQVRNKJHWKZAKO-UHFFFAOYSA-N beta-N-Acetyl-D-neuraminic acid Natural products CC(=O)NC1C(O)CC(O)(C(O)=O)OC1C(O)C(O)CO SQVRNKJHWKZAKO-UHFFFAOYSA-N 0.000 description 1
- 230000027455 binding Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 210000003837 chick embryo Anatomy 0.000 description 1
- 238000005352 clarification Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 230000008144 egg development Effects 0.000 description 1
- 230000013020 embryo development Effects 0.000 description 1
- 230000001424 embryocidal effect Effects 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 238000013213 extrapolation Methods 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 108010008385 glycolipid receptor Proteins 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000002163 immunogen Effects 0.000 description 1
- 230000000415 inactivating effect Effects 0.000 description 1
- 230000009349 indirect transmission Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 239000012678 infectious agent Substances 0.000 description 1
- 208000037800 influenza D Diseases 0.000 description 1
- 210000000994 inner shell membrane Anatomy 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 108010026228 mRNA guanylyltransferase Proteins 0.000 description 1
- 230000013011 mating Effects 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 210000000993 outer shell membrane Anatomy 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 208000008494 pericarditis Diseases 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000005559 respiratory droplet transmission Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 206010039083 rhinitis Diseases 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000000405 serological effect Effects 0.000 description 1
- 125000005629 sialic acid group Chemical group 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 208000009174 transverse myelitis Diseases 0.000 description 1
- 230000007502 viral entry Effects 0.000 description 1
- 244000052613 viral pathogen Species 0.000 description 1
- 208000009421 viral pneumonia Diseases 0.000 description 1
- 229960004854 viral vaccine Drugs 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 229940051021 yellow-fever virus Drugs 0.000 description 1
- -1 yolk Substances 0.000 description 1
- 210000001325 yolk sac Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A47—FURNITURE; DOMESTIC ARTICLES OR APPLIANCES; COFFEE MILLS; SPICE MILLS; SUCTION CLEANERS IN GENERAL
- A47J—KITCHEN EQUIPMENT; COFFEE MILLS; SPICE MILLS; APPARATUS FOR MAKING BEVERAGES
- A47J43/00—Implements for preparing or holding food, not provided for in other groups of this subclass
- A47J43/14—Devices or machines for opening raw eggs or separating the contents thereof
- A47J43/145—Machines therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16151—Methods of production or purification of viral material
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Public Health (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Mechanical Engineering (AREA)
- Food Science & Technology (AREA)
- Pulmonology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Meat, Egg Or Seafood Products (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US94898207P | 2007-07-10 | 2007-07-10 | |
| US60/948,982 | 2007-07-10 | ||
| PCT/US2008/069660 WO2009009670A2 (fr) | 2007-07-10 | 2008-07-10 | Appareil et procédé pour récolter des substances biologiques provenant d'œufs |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2692744A1 true CA2692744A1 (fr) | 2009-01-15 |
| CA2692744C CA2692744C (fr) | 2014-06-03 |
Family
ID=40229482
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2692744A Expired - Fee Related CA2692744C (fr) | 2007-07-10 | 2008-07-10 | Appareil et procede pour recolter des substances biologiques provenant d'oeufs |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US8011294B2 (fr) |
| EP (1) | EP2173865B1 (fr) |
| CA (1) | CA2692744C (fr) |
| ES (1) | ES2613045T3 (fr) |
| HU (1) | HUE030516T2 (fr) |
| MX (1) | MX2010000454A (fr) |
| WO (1) | WO2009009670A2 (fr) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8418943B2 (en) * | 2005-01-18 | 2013-04-16 | Biova, L.L.C. | Egg shell membrane separation |
| US20110189720A1 (en) * | 2010-02-01 | 2011-08-04 | Ron Goldstein | Automated biological sample collection system and method |
| BE1019291A3 (nl) * | 2010-04-15 | 2012-05-08 | Innovatec B V | Inrichting voor het schouwen en overleggen van eieren en een werkwijze daarbij toegepast. |
| MX2017003369A (es) * | 2014-09-15 | 2017-06-28 | Zoetis Services Llc | Aparato para remover el extremo superior del huevo, y su metodo asociado. |
| PT3709795T (pt) * | 2017-11-14 | 2024-06-25 | Seleggt Gmbh | Suporte de ovos e aparelho para manuseio de ovos |
| CN115386454A (zh) * | 2022-09-06 | 2022-11-25 | 吉林正业生物制品股份有限公司 | 一种便于操作的鸡胚尿囊液收集装置 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2524844A (en) * | 1947-10-22 | 1950-10-10 | Earl D Smith | Egg opening means |
| US3470925A (en) * | 1966-12-29 | 1969-10-07 | Parke Davis & Co | Machine for opening eggs to permit removal of viral products therefrom |
| US3973482A (en) * | 1974-10-24 | 1976-08-10 | Sio Pway Khee | Appliance for cutting half-boiled eggs |
| US3958505A (en) * | 1974-11-21 | 1976-05-25 | Lamar Baker | Egg cracking machine |
| USRE33164E (en) * | 1979-05-15 | 1990-02-13 | Mobay Corporation | Influenza vaccine production in liquid cell culture |
| NL9002455A (nl) * | 1990-11-09 | 1992-06-01 | Food Processing Systems | Eibreker. |
| US5197380A (en) * | 1991-06-19 | 1993-03-30 | Fisher Patrick T | Egg breaking machine |
| US5324768A (en) * | 1992-07-17 | 1994-06-28 | Inland Coatings Corporation | Metal sealing composition |
| JP3550415B2 (ja) * | 1994-01-21 | 2004-08-04 | 財団法人化学及血清療法研究所 | 胚採取装置 |
| JPH0928302A (ja) * | 1995-07-18 | 1997-02-04 | Q P Corp | 割卵装置 |
| US5628246A (en) * | 1996-03-01 | 1997-05-13 | Sanovo Engineering A/S | Egg processing machine |
-
2008
- 2008-07-10 WO PCT/US2008/069660 patent/WO2009009670A2/fr not_active Ceased
- 2008-07-10 ES ES08781620.3T patent/ES2613045T3/es active Active
- 2008-07-10 EP EP08781620.3A patent/EP2173865B1/fr not_active Not-in-force
- 2008-07-10 HU HUE08781620A patent/HUE030516T2/en unknown
- 2008-07-10 CA CA2692744A patent/CA2692744C/fr not_active Expired - Fee Related
- 2008-07-10 MX MX2010000454A patent/MX2010000454A/es active IP Right Grant
- 2008-07-10 US US12/171,087 patent/US8011294B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP2173865B1 (fr) | 2016-11-16 |
| WO2009009670A2 (fr) | 2009-01-15 |
| MX2010000454A (es) | 2010-04-22 |
| US20090053803A1 (en) | 2009-02-26 |
| WO2009009670A3 (fr) | 2009-03-12 |
| US8011294B2 (en) | 2011-09-06 |
| EP2173865A2 (fr) | 2010-04-14 |
| CA2692744C (fr) | 2014-06-03 |
| EP2173865A4 (fr) | 2014-11-26 |
| WO2009009670A4 (fr) | 2009-06-04 |
| ES2613045T3 (es) | 2017-05-22 |
| HUE030516T2 (en) | 2017-05-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2173865B1 (fr) | Appareil et procede pour recolter des substances biologiques provenant d'oeufs | |
| US7879336B2 (en) | Vaccines and methods to treat canine influenza | |
| EP2284190B1 (fr) | Facteur de transfert depuis des 'ufs d'oiseaux | |
| Witter et al. | Epidemiology of a herpesvirus of turkeys: possible sources and spread of infection in turkey flocks | |
| Manvell et al. | Experimental assessment of the pathogenicity of two avian influenza A H5 viruses in ostrich chicks (Struthio camelus) and chickens | |
| US20120128716A1 (en) | Vaccine Compositions | |
| Eidson et al. | A comparison of various routes of Newcastle disease vaccination at one day of age | |
| Raghul et al. | Protection of the reproductive tract of young chicks by Newcastle disease virus-induced haemagglutinationinhibition antibodies | |
| Kapczynski | Development of a virosome vaccine against avian metapneumovirus subtype C for protection in turkeys | |
| Brigleb et al. | Effects of oral exposure to HPAI H5N1 pasteurized in milk on immune response and mortality in mice | |
| JP7705878B2 (ja) | 弱毒化トリレオウイルス９４８２６ ｃ１４０株及び９６１３９ ｃ１４０株 | |
| NO320871B1 (no) | Inaktivert, immunogent effektiv og ikke-reaktiv Chlamydia psittaci vaksine, og fremgangsmater for fremstilling derav. | |
| KR0142081B1 (ko) | 개의 코로나 바이러스 백신 | |
| CN105866424A (zh) | 一种鸭坦布苏病毒病灭活疫苗的效力检验方法 | |
| RU94015927A (ru) | Штамм palamyxovirus гам-61 вгнки, используемый для изготовления вакцины против ньюкаслской болезни кур | |
| RU2830499C1 (ru) | Аттенуированные штаммы реовируса птиц 94826 c140 и 96139 c140 | |
| KR100556275B1 (ko) | 클라미디아시타시를함유하는고양이백신및그의제조방법 | |
| AU2025256140A1 (en) | Eimeria vaccine | |
| Khan et al. | In process quality control factors affecting efficacy of Avian Influenza (H5N1) vaccine | |
| YOUSSEF et al. | Estimation of rotavirus antibodies in vaccinated cattle and their neonates | |
| TW202516000A (zh) | 利用雞蛋培養法進行的去活化流感疫苗的製備方法 | |
| Klausz | Mycoplasma synoviae from the primary breeder's perspective. | |
| KA Kassem | LABORATORY IMMUNE RESPONSE AGAINST ROTA VIRUS FREEZE DRIED INACTIVATED VACCINE IN BUFFALO CALVES | |
| MURUGAN | IMMUNOGENICITY OF AIM INDIGENOUS ISOLATE OF NEWCASTLE DISEASE VIRUS AND ITS USEFULNESS AS A VACCINE STRAIN | |
| Gandhi | The relative immunogenicity in mice of whole and split influenza virus |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKLA | Lapsed |
Effective date: 20220301 |
|
| MKLA | Lapsed |
Effective date: 20200831 |